Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Cogent Biosciences, Inc. (COGT) had Return on Equity of -18.74% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-102.49M |
|
-- |
|
-- |
|
$99.49M |
|
$-99.49M |
|
$-3.00M |
|
$-102.49M |
|
$-102.49M |
|
$-102.49M |
|
$-102.49M |
|
$-102.49M |
|
$-102.49M |
|
$-99.49M |
|
$-99.68M |
|
128.90M |
|
128.90M |
|
$-0.61 |
|
$-0.61 |
|
| Balance Sheet Financials | |
$910.36M |
|
$5.46M |
|
$27.25M |
|
$937.61M |
|
$63.95M |
|
$222.90M |
|
$237.28M |
|
$301.24M |
|
$546.98M |
|
$636.37M |
|
$636.37M |
|
160.98M |
|
| Cash Flow Statement Financials | |
$-264.44M |
|
$-399.53M |
|
$878.23M |
|
$98.17M |
|
$312.43M |
|
$214.26M |
|
$46.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.23 |
|
-- |
|
-- |
|
0.26 |
|
0.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-266.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-18.74% |
-16.11% |
|
-10.93% |
|
-11.93% |
|
$3.95 |
|
$-2.06 |
|
$-2.05 |
|